文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

多重PCR联合质谱检测淋球菌耐药标志物的新方法

A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

本研究开发了基于多重PCR与MALDI-TOF质谱联用的NG-AMR-MS方法,可同时筛查19个淋球菌耐药基因座上的24个突变。用454株淋球菌分离株、8株非淋球菌奈瑟菌、214份临床样本及3个质粒评估显示,方法特异性100%,灵敏度低至每反应10拷贝,临床样本菌量>5拷贝/μL时可准确识别20个耐药突变。

要点

  • NG-AMR-MS可单次检测19个耐药基因座的24个突变,覆盖多种抗菌药物。
  • 方法特异性100%,灵敏度除PorB A121D/N/G为100拷贝/反应外,其余低至10拷贝/反应。
  • 临床样本菌量>5拷贝/μL时可准确识别20个耐药突变,并成功检出penA A311V突变株。

核心结论

  • NG-AMR-MS高通量方法可提供全面的淋球菌耐药谱,并直接用于临床样本筛查。

研究设计与样本

  • 开发基于多重PCR与MALDI-TOF质谱联用的NG-AMR-MS方法,用于筛查19个淋球菌耐药基因座的24个突变。
  • 性能评估使用454株淋球菌分离株(已知6种抗生素MIC)、8株非淋球菌奈瑟菌、214份临床样本和3个含确认mosaic penA等位基因的质粒。

主要发现

  • NG-AMR-MS特异性为100%,灵敏度低至每反应10拷贝(PorB A121D/N/G为每反应100拷贝)。
  • 对淋球菌载量>5拷贝/μL的临床样本,方法可准确识别20个耐药突变。
  • 方法成功检测出penA等位基因A311V突变相关的特定头孢菌素耐药株。

临床怎么用

  • 该方法可用于临床样本直接筛查淋球菌耐药突变,辅助耐药监测。
  • 对菌量>5拷贝/μL的临床样本可准确识别20个耐药突变,适合高通量监测。
  • 可检测头孢菌素耐药相关的mosaic penA A311V突变,有助于监控耐药株扩散。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complicated mechanisms and variable determinants related to drug resistance pose a major challenge to obtain comprehensive antimicrobial resistance (AMR) profiles of Neisseria gonorrhoeae. Meanwhile, cephalosporin-resistant mosaic penA alleles have been reported worldwide. Therefore, it is urgent to monitor the expansion of cephalosporin-resistant mosaic penA alleles. OBJECTIVES: To develop a comprehensive high-throughput method to efficiently screen AMR determinants. METHODS: We developed a method based on multiplex PCR with MALDI-TOF MS, which can simultaneously screen for 24 mutations associated with multiple antimicrobial agents in 19 gonococcal AMR loci (NG-AMR-MS). The performance of the NG-AMR-MS method was assessed by testing 454 N. gonorrhoeae isolates with known MICs of six antibiotics, eight non-gonococcal Neisseria strains, 214 clinical samples and three plasmids with a confirmed mosaic penA allele. RESULTS: The results show that NG-AMR-MS had a specificity of 100% with a sensitivity as low as 10 copies per reaction (except for PorB A121D/N/G, 100 copies per reaction). For clinical samples with gonococcal load >5 copies/μL, the method can accurately identify 20 AMR mutations. In addition, the method successfully detected specific cephalosporin-resistant strains with the A311V mutation in the penA allele. CONCLUSIONS: Our high-throughput method can provide comprehensive AMR profiles within a multiplex format. Furthermore, the method can be directly applied to screening for AMR among clinical samples, serving as an effective tool for overall monitoring of N. gonorrhoeae AMR and also provides a powerful means to comprehensively improve the level of monitoring.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Li Y, Xiu L, Liu J, et al. A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry. J Antimicrob Chemother. 2020. PMID: 32688393. doi:10.1093/jac/dkaa269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。